Product Images Kloxxado
View Photos of Packaging, Labels & Appearance
- peeling-back-blister-with-zoom-of-triangle - image 01
- figure-1(a)-naloxone-hcl-ns-8mg-with-stand-dev - image 02
- figure-1(b)-naloxone-hcl-ns-8mg-with-stand-dev - image 03
- kloxxado-fc-c50001063-02-k03 - image 04
- ifu-image-2-proper-way-to-hold-device - image 05
- ifu-image-3-support-back-of-neck - image 06
- ifu-image-4-insert-tip-into-nostril - image 07
- ifu-image-5-place-patient-on-their-side - image 08
- ifu-image-6-clock-2-3-minutes - image 09
- image 10
- image 11
- image 12
- image-chemical-structure-usp.jpg - image chemical structure usp
Product Label Images
The following 13 images provide visual information about the product associated with Kloxxado NDC 59467-679 by Hikma Specialty Usa Inc., such as packaging, labeling, and the appearance of the drug itself. This resource could be helpful for medical professionals, pharmacists, and patients seeking to verify medication information and ensure they have the correct product.
peeling-back-blister-with-zoom-of-triangle - image 01
figure-1(a)-naloxone-hcl-ns-8mg-with-stand-dev - image 02
This is a graph that shows the mean concentration of Naloxone in plasma in ng/mL at different time intervals for different routes of administration. The routes of administration tested were nasal spray, intravenous injection, and intramuscular injection. The concentration is highest for intravenous injection and lowest for intramuscular injection. The graph is a comparison of studies I, I1, and II.*
figure-1(b)-naloxone-hcl-ns-8mg-with-stand-dev - image 03
The text represents a graphical table showing the mean concentration of Naloxone in plasma (ng/ml) over time (hr) for different administration methods in different studies. The adminstration methods are Nasal Spray 8 mg, Intravenous Injection 2 mg, and Intramuscular Injection 0.4 mg. The range of Naloxone concentration is from 0.05 to 35 ng/ml, and the time range is from 0.5 to 1 hr.*
kloxxado-fc-c50001063-02-k03 - image 04
ifu-image-2-proper-way-to-hold-device - image 05
ifu-image-3-support-back-of-neck - image 06
ifu-image-4-insert-tip-into-nostril - image 07
ifu-image-5-place-patient-on-their-side - image 08
ifu-image-6-clock-2-3-minutes - image 09
Kloxxado is a nasal spray indicated for the treatment of known or suspected opioid overdose. It should not be removed until ready for use and device testing before use is not recommended. The product comes in a pack of two and its expiration date should be checked before use. Each nasal spray contains 8 mg of medication.*
image 10
NDC 59467-679-01 is a prescription nasal spray called QR Kloxxad 0. It contains 8mg of naloxone HC per unit dose spray and is intended for use in the nose only. It is to be used for known or suspected opioid overdose but should not be used above 40°C (104°F) or after freezing. The device should not be tested before use and quick instructions are included.*
image 11
image 12
image-chemical-structure-usp.jpg - image chemical structure usp
* The product label images have been analyzed using a combination of traditional computing and machine learning techniques. It should be noted that the descriptions provided may not be entirely accurate as they are experimental in nature. Use the information in this page at your own discretion and risk.
